Clinical trial
Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer
NCT00209742 · Hokkaido Gastrointestinal Cancer Study Group, Other · Unknown status
Key facts
| NCT number | NCT00209742 |
|---|---|
| Title | Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer |
| Official title | Randomized Phase III Clinical Study Comparing Postoperative UFT+LV, UFT+LV/UFT and UFT+LV+PSK/UFT+PSK Therapies for Stage III Colorectal Cancer |
| Lead sponsor | Hokkaido Gastrointestinal Cancer Study Group, Other |
| Collaborators | Hokkaido University Hospital |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | UFT, USEL/Leucovorin, Krestin |
| Enrollment | 340 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Sep 21, 2005 |
| Last update posted | May 26, 2010 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: